With COVID-19 vaccinations beginning this week in the US, the country is entering a new stage of the pandemic that could ultimately end in widespread suppression of the virus. The implications of this ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
On February 4, 2020, the U.S. secretary of health and human services declared that emergency use of diagnostics for SARS-CoV-2 was justified, triggering emergency authority for the Food and Drug ...
EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics, Inc., (Minute Molecular) today announced it has been awarded a $21.3 million contract from the U.S. National Institutes of Health (NIH) ...
"We're thrilled to partner with Molecular Lab Partners to bring rapid, scalable solutions to POLs and urgent care labs nationwide. Together, we're helping to advance diagnostics by making operations ...
Roche Diagnostics has launched its new molecular laboratory instrument, the cobas ® 5800 System, in the UK. Through improved automation the new system can help raise testing volumes, improve ...
According to DataM Intelligence AUSTIN, Texas and TOKYO, Nov. 18, 2025 /PRNewswire/ -- DataM Intelligence announces the latest insights into the rapidly transforming Oncology Molecular Diagnostics ...
The Clinical Laboratory Tests Market offers key opportunities in expanding molecular diagnostics, oncology care, and infectious disease testing. Automation and AI promise to enhance efficiency and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results